Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AlloForB: budesonide/formoterol for fixed bronchial obstructive syndrome after allogeneic hematopoietic stem cell transplantation
2007-004484-22Phase 2Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of budesonide in Bronchiolitis Obliterans Syndrome (BOS) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Absolute change in FEV1 after 1 month of treatment. Started Feb 2008; status: active.
02
Drugs
budesonide
03
Conditions
Bronchiolitis Obliterans Syndrome (BOS)
Beyond the preview
Go deeper on 2007-004484-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004484-22.